MyD88/CD40 signaling retains CAR T cells in a less differentiated state

類似資料

• Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
  著者:: Mata, Melinda, 等
  出版事項: (2017)
• MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy
  著者:: Mata, Melinda, 等
  出版事項: (2015)
• Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells
  著者:: Wang, Xiaomei, 等
  出版事項: (2020)
• CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?
  著者:: Prinzing, Brooke L., 等
  出版事項: (2018)
• Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?
  著者:: Prinzing, Brooke, 等
  出版事項: (2021)